Norris Perne & French LLP MI Increases Stock Holdings in Avantor, Inc. (NYSE:AVTR)

Norris Perne & French LLP MI boosted its holdings in Avantor, Inc. (NYSE:AVTR) by 1.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 500,662 shares of the company’s stock after buying an additional 8,966 shares during the period. Norris Perne & French LLP MI’s holdings in Avantor were worth $10,549,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio lifted its holdings in shares of Avantor by 34.1% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 346,822 shares of the company’s stock worth $8,972,000 after acquiring an additional 88,205 shares during the period. Perpetual Ltd raised its position in shares of Avantor by 38.7% in the 4th quarter. Perpetual Ltd now owns 1,766,882 shares of the company’s stock worth $37,228,000 after buying an additional 493,408 shares during the period. New York State Teachers Retirement System purchased a new stake in Avantor during the third quarter valued at about $8,473,000. Everence Capital Management Inc. acquired a new stake in Avantor during the fourth quarter worth about $555,000. Finally, Teachers Retirement System of The State of Kentucky increased its stake in Avantor by 45.8% during the third quarter. Teachers Retirement System of The State of Kentucky now owns 723,178 shares of the company’s stock worth $18,708,000 after acquiring an additional 227,200 shares during the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on AVTR. Wells Fargo & Company decreased their target price on Avantor from $30.00 to $28.00 and set an “overweight” rating for the company in a report on Monday, October 28th. UBS Group restated a “neutral” rating and set a $25.00 target price (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Robert W. Baird lowered their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Raymond James reduced their price objective on Avantor from $29.00 to $26.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 21st. Finally, Barclays lowered their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. According to MarketBeat, Avantor currently has an average rating of “Moderate Buy” and an average price target of $27.38.

Avantor Stock Performance

Avantor stock opened at $22.22 on Friday. The company has a current ratio of 1.54, a quick ratio of 1.06 and a debt-to-equity ratio of 0.84. The stock has a 50 day moving average of $21.63 and a 200-day moving average of $23.43. The stock has a market cap of $15.12 billion, a P/E ratio of 48.29, a price-to-earnings-growth ratio of 3.53 and a beta of 1.28. Avantor, Inc. has a 52 week low of $19.59 and a 52 week high of $28.00.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.